Carregant...
Does Targeting the Lipophilic Milieu Provide Advantages for an Endothelin Antagonist?
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Pharmacology and Experimental Therapeutics
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2800997/ https://ncbi.nlm.nih.gov/pubmed/19401539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mi.9.2.6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|